Medicare plans trial coverage for obesity drugs, GLP-1 opportunities amid foodtech slump, Novo continues taking L's, Lilly's new oral GLP-1 is pretty mid, and more!
The Gut Punch Weekly #29
Medicare plans trial coverage for obesity drugs, GLP-1 opportunities amid foodtech slump, Novo continues taking L's, Lilly's new oral GLP-1 is pretty mid, and more!